Arrowhead Pharmaceuticals, Inc. (ARWR) Financials

ARWR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 626.3 million 452.6 million
2023-09-30 765.6 million 478.4 million
2023-06-30 795.9 million 413.9 million
2023-03-31 891.3 million 426.2 million

ARWR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -186.5 million 19.7 million
2023-09-30 -89.2 million 18.2 million
2023-06-30 -68.1 million 19.9 million
2023-03-31 -59.0 million 20.6 million

ARWR Net Income

No data available :(

ARWR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 220.3 million - 118.6 million
2023-09-30 403.6 million - 115.2 million
2023-06-30 451.7 million - 82.7 million
2023-03-31 481.0 million - 82.8 million

ARWR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 107.4 million
2023-09-30 106.8 million
2023-06-30 107.0 million
2023-03-31 108.1 million

ARWR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 68.7 million 116.5 million 23.2 million -
2023-09-30 63.9 million 99.9 million 24.2 million -
2023-06-30 46.6 million 94.8 million 23.4 million -
2023-03-31 27.3 million 74.9 million 22.8 million -

ARWR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.6 million 4.3 million
2023-09-30 16.1 million 3.9 million
2023-06-30 15.8 million 3.3 million
2023-03-31 146.3 million 2.7 million

ARWR

Price: $22.12

52 week price:
20.67
42.48

Payout Ratio Range:
-325.06%
666.08%

Earnings Per Share: -2.77 USD

P/E Ratio: -16.48

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 594870

Ebitda: -12.7 million

Market Capitalization: 3.2 billion

Links: